Julie Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Cardiovascular Risk Factors

Top Venues

Journal of thrombosis and thrombolysis

Diagnostics (Basel, Switzerland)

Journal of personalized medicine

International journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Wang, Prahlad Ho, Harshal Nandurkar, Hui Yin Lim
Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases. Journal of thrombosis and thrombolysis 57 (5) (2024)
Julie Wang, Prahlad Ho, Harshal Nandurkar, Hui Yin Lim
Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases. Journal of thrombosis and thrombolysis (2024)
Julie Wang, Hui Yin Lim, Harshal Nandurkar, Prahlad Ho
DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays. International journal of laboratory hematology (2023)
Julie Wang, Elise Smeath, Hui Yin Lim, Harshal Nandurkar, Hong Kuan Kok, Prahlad Ho
Current challenges in the prevention and management of post-thrombotic syndrome-towards improved prevention. International journal of hematology (2023)
Blake McLeod, Hui Yin Lim, Harshal Nandurkar, Prahlad Ho, Julie Wang
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Hui Yin Lim, Sheila K Patel, Ping Huang, Mark Tacey, Kay Weng Choy, Julie Wang, Geoffrey Donnan, Harshal H Nandurkar, Prahlad Ho, Louise M Burrell
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease. Journal of personalized medicine 12 (9) (2022)
Julie Wang, Hui Yin Lim, Rowena Brook, Jeffrey Lai, Harshal Nandurkar, Prahlad Ho
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients. Journal of thrombosis and thrombolysis (2022)
Blake McLeod, Hui Yin Lim, Harshal Nandurkar, Prahlad Ho, Julie Wang
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Julie Wang, Kay Weng Choy, Hui Yin Lim, Prahlad Ho
Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation? Internal and emergency medicine (2022)
Blake McLeod, Hui Yin Lim, Harshal Nandurkar, Prahlad Ho, Julie Wang
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Julie Wang, Kay Weng Choy, Hui Yin Lim, Prahlad Ho
Impaired Fibrinolytic Potential Predicts Oxygen Requirement in COVID-19. Journal of personalized medicine 12 (10) (2022)